Viewing Study NCT01336335


Ignite Creation Date: 2025-12-24 @ 10:04 PM
Ignite Modification Date: 2025-12-31 @ 3:07 AM
Study NCT ID: NCT01336335
Status: UNKNOWN
Last Update Posted: 2011-04-15
First Post: 2011-04-13
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: The Effects of Continuous Positive Airway Pressure (CPAP) on Sympathetic Activity in Different Sites of Activation
Sponsor: University of Sao Paulo
Organization:

Study Overview

Official Title: The Effects of Continuous Positive Airway Pressure (CPAP) on Sympathetic Activity in Different Sites of Activation
Status: UNKNOWN
Status Verified Date: 2010-07
Last Known Status: ACTIVE_NOT_RECRUITING
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Recent evidences suggest that obstructive sleep apnea (OSA) can contribute to cardiovascular disease even in the absence of hypertension. However, there are few data regarding the impact of OSA on the sympathetic system in apparently normotensive patients with OSA as well as the impact of treatment with continuous positive airway pressure in different sites of activation (heart, peripheral nerves and circulating catecholamines)
Detailed Description: None

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: